Skip to main content

Whole-genome amplified DNA from stored dried blood spots is reliable in high resolution melting curve and sequencing analysis.

Winkel BG, Hollegaard MV, Olesen MS, Svendsen JH, Haunsø S, Hougaard DM, Tfelt-Hansen J

Publication: BMC Med Genet (2011) • Vol 12 • Page 22PMID: 21306642View on PubMed

Purpose

The purpose of this paper was to determine if whole genome amplified (WGA) DNA from dried blood spots (DBS) stored at -20 degrees C for 19-28 years have comparable melting curves and sequencing results to fresh liquid blood specimens from patients with atrial fibrillation.

Conclusion

Melting curve analysis of 40 amplicons in 10 patients revealed 85 (21%) and 81 (20%) alterations from wild-type using WGA-DBS DNA and fresh genomic DNA, respectively. Although, 64% and 62% of the alterations using WGA-DBS and fresh blood, respectively, were determined to be false positives after sequencing. By sequencing, the same 31 variants were identified using DNA from WGA-DBS and fresh DNA.

Studies (1)

Purpose

The purpose of this study was to determine if WGA-DBS stored frozen for 19-28 years have comparable melting curves and sequencing results to fresh blood specimens from patients with atrial fibrillation. DBS obtained at patient birth were stored at -20 degrees C for 19-28 years. DNA was extracted from DBS by Extract-N-amp Blood PCR Kit and amplified with REPLI-g. Fresh blood was obtained from the same patients, and DNA was extracted using the QIAamp mini blood kit. Melting curves were evaluated by high resolution melting curve analysis.

Summary of Findings

Melting curve analysis of 40 amplicons in 10 patients revealed 85 (21%) and 81 (20%) alterations from wild-type using WGA-DBS DNA and fresh genomic DNA, respectively. Although, 64% and 62% of the alterations using WGA-DBS and fresh blood, respectively, were determined to be false positives after sequencing. By sequencing, the same 31 variants were identified using DNA from WGA-DBS and fresh DNA and included 29 heterogeneous and 2 homogeneous changes.

  • Biospecimens

    FluidBlood
  • Preservation Types

    Other PreservativeFrozenNone (Fresh)
  • Diagnoses

    Cardiovascular Disease
    Other diagnoses
  • Platforms

    DNADNA sequencing
    DNASNP assay
    DNAWhole genome amplification
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Atrial fibrillation
    Biospecimen PreservationType of fixation/preservation
    Air-dried
    Frozen
    None (fresh)
    StorageStorage duration
    0 days
    19-28 years
    Analyte Extraction and PurificationAnalyte isolation method
    Extract-N-amp Blood PCR Kit
    QIAamp mini kit
    SNP assay SpecificNucleic acid amplification
    None
    REPLI-g
    SNP assay SpecificTargeted nucleic acid
    KCNA5
    SCN5A
    SNP assay SpecificTechnology platform
    DNA sequencing
    High resolution melting curve analysis